- Home
- CHAR vs RVPHW Comparison
CHAR vs RVPHW Comparison
Compare CHAR & RVPHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHAR
- RVPHW
- Stock Information
- Founded
- CHAR 2024
- RVPHW N/A
- Country
- CHAR United States
- RVPHW United States
- Employees
- CHAR N/A
- RVPHW 15
- Industry
- CHAR
- RVPHW Biotechnology: Pharmaceutical Preparations
- Sector
- CHAR
- RVPHW Health Care
- Exchange
- CHAR NYSE
- RVPHW Nasdaq
- Market Cap
- CHAR N/A
- RVPHW N/A
- IPO Year
- CHAR 2024
- RVPHW 2018
- Fundamental
- Price
- CHAR $9.95
- RVPHW $0.14
- Analyst Decision
- CHAR
- RVPHW
- Analyst Count
- CHAR 0
- RVPHW 0
- Target Price
- CHAR N/A
- RVPHW N/A
- AVG Volume (30 Days)
- CHAR 38.5K
- RVPHW N/A
- Earning Date
- CHAR 01-01-0001
- RVPHW N/A
- Dividend Yield
- CHAR N/A
- RVPHW N/A
- EPS Growth
- CHAR N/A
- RVPHW N/A
- EPS
- CHAR N/A
- RVPHW N/A
- Revenue
- CHAR N/A
- RVPHW N/A
- Revenue This Year
- CHAR N/A
- RVPHW N/A
- Revenue Next Year
- CHAR N/A
- RVPHW N/A
- P/E Ratio
- CHAR N/A
- RVPHW N/A
- Revenue Growth
- CHAR N/A
- RVPHW N/A
- 52 Week Low
- CHAR $9.95
- RVPHW N/A
- 52 Week High
- CHAR $10.20
- RVPHW N/A
- Technical
- Relative Strength Index (RSI)
- CHAR N/A
- RVPHW N/A
- Support Level
- CHAR N/A
- RVPHW N/A
- Resistance Level
- CHAR N/A
- RVPHW N/A
- Average True Range (ATR)
- CHAR 0.00
- RVPHW 0.00
- MACD
- CHAR 0.00
- RVPHW 0.00
- Stochastic Oscillator
- CHAR 0.00
- RVPHW 0.00
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.